Recent work from our group showed that PI3K/AKT pathway was enriched according to the whole-exome sequencing (WES) results from eleven treatment-naïve and paired recurrent SCLC patients treated with CCRT [7]. This evidence concerns the gene PIK3CA and small cell lung carcinoma.